De novo assay development holds great promise for future drug discovery projects, potentially reducing costs, improving success rates, and ultimately benefiting patients by accelerating the development of safe and effective therapeutics. Download our white paper to learn what you need to know with regard to new biomarker assay development.
Type: White Paper
WHITE PAPER: IMPROVEMENTS TO PS80 DETECTION IN DRUG PRODUCT FORMULATIONS This technical white paper details Prolytix’s mixed-mode high-performance liquid chromatography method for the determination of polysorbates, such as PS80. The method offers notable improvements over a conventional reverse-phase HPLC method. The paper includes discussion of: Download now.
Using mass spectrometry to identify and quantify HCPs enables a more rational development of robust purification processes.